OTC Markets Group Inc. (OTCM: OTCQX U.S. Premier) |

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
OTC Markets Group Inc. (OTCM: OTCQX U.S. Premier) | Cynapsus Therapeutics Begins Trading on OTCQX® Cynapsus Therapeutics Begins Trading on OTCQX®

Cynapsus Therapeutics Begins Trading on OTCQX®

PR Newswire

NEW YORK , July 18, 2013 /PRNewswire/ --  OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Cynapsus Therapeutics Inc. (OTCQX: CYNAF; TSX.V: CTH), a Canada -based specialty pharmaceutical company, has been approved to trade on OTCQX®, the best marketplace with qualified companies.

(Logo: http://photos.prnewswire.com/prnh/20110118/MM31963LOGO )

Cynapsus Therapeutics began trading today on OTCQX International, a segment of the OTCQX marketplace reserved for high-quality non-U.S. companies that are listed on a qualified international exchange, undergo management reviews and provide their home country disclosure to U.S. investors.  U.S. investors can find current financial disclosures and Real-Time Level 2 quotes for the company on www.otcmarkets.com .

"We are pleased to welcome Cynapsus Therapeutics to OTCQX," said R. Cromwell Coulson , President and CEO of OTC Markets Group.  "OTCQX provides qualifying companies like Cynapsus the ability to distinguish themselves in the U.S. market and increase their visibility with traders, investors, analysts and the media through high-quality disclosure, transparent trading and ease of access to company information.  We look forward to supporting the management team at Cynapsus as they continue to grow the company and provide a robust public market for their shares."

"Qualifying for OTCQX is an important milestone for Cynapsus and demonstrates our commitment to providing our U.S. investors convenient access to the same timely news and information enjoyed by investors in our home market," said Anthony Giovinazzo , President and CEO of Cynapsus Therapeutics.

Troutman Sanders LLP will serve as Cynapsus Therapeutics' Principal American Liaison ("PAL") on OTCQX, responsible for providing professional guidance on OTCQX requirements and U.S. securities laws.

Cynapsus is a specialty pharmaceutical company developing the only non-injectable (i.e., sublingual) delivery of the only approved drug (apomorphine) to be used as a rescue therapy for "off" motor symptoms of Parkinson's disease.

Cynapsus Therapeutics trades in the U.S. on OTCQX under the symbol "CYNAF."

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace with Qualified Companies; OTCQB®, The Venture Stage Marketplace with U.S. Reporting Companies; and OTC Pink®, The Open Marketplace with Variable Reporting Companies. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com .

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

SOURCE OTC Markets Group Inc.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 42

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 569

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 101

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 94

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 81

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 42

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 17

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 103

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
tion End -->

Top 5 Most Recently Viewed Articles

Investors Eye Holiday Spending Surge with Retail ETFs

Updated Category News Views 230

Holiday Spending Trends Point to Retail ETF Gains As the festive season kicks off, investors are buzzing with anticipation. The projections indicate a remarkable surge in U.S. holiday sales, expected to hit between $1.01 trillion and $1.02 trillion. This optimism is driven by strong consumer demand, early sales promotions, and a decrease in inflation, setting a promising...

Continue Reading
Titan Mining Announces Details for Upcoming AGM Meeting

Updated Category News Views 263

Titan Mining Corporation's Upcoming Annual General Meeting Titan Mining Corporation (TSX: TI; OTCQB: TIMCF) is set to hold its annual general meeting soon, a much-anticipated event for shareholders and stakeholders alike. The date is indeed significant as it marks an opportunity for the company to engage directly with its investors. Meeting Details and Importance The...

Continue Reading
She Said Yes Launches Eco-Friendly Jewelry Initiative

Updated Category News Views 219

She Said Yes Empowers Customers with Tree-Planting Initiative She Said Yes, a renowned jewelry brand dedicated to using conflict-free diamonds and recycled gold, has unveiled an exciting partnership with WeForest to create a meaningful environmental initiative. This new program enables every jewelry purchase to contribute directly to global reforestation efforts,...

Continue Reading
Whale Traders Target Trump Media's Future with Options Movements

Updated Category News Views 121

Whale Traders Target Trump Media's Future with Options Movements Recently, investors with substantial capital have been showing strong interest in Trump Media & Technology (NASDAQ: DJT). This surge in activity is a signal that retail traders should pay attention to. Today, unusual trading patterns have been detected, hinting that significant financial players are...

Continue Reading
Partnership Boosts Digital Transformation in Japan's Life Sciences

Updated Category News Views 153

Transforming the Life Sciences Industry through Digital Solutions ValGenesis Inc. has teamed up with Hitachi Industry & Control Solutions, Ltd. to spearhead a transformative initiative aimed at elevating the capabilities of life sciences companies in Japan. This innovative partnership intends to bring forth cutting-edge digital validation solutions to streamline processes...

Continue Reading